Walleye Capital
TEVA icon

Walleye Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Walleye Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.1M Buy
239,000
+90,500
+61% +$3.01M 0.03% 570
2026
Q1 		$4.47M Sell
148,500
-208,800
-58% -$6.72M 0.02% 867
2025
Q4 		$11.2M Buy
357,300
+257,000
+256% +$6.33M 0.03% 588
2025
Q3 		$2.03M Sell
100,300
-8,400
-8% -$148K 0.01% 1567
2025
Q2 		$1.82M Sell
108,700
-22,000
-17% -$355K 0.01% 1589
2025
Q1 		$2.01M Sell
130,700
-344,700
-73% -$6.16M 0.01% 1411
2024
Q4 		$10.5M Buy
475,400
+109,200
+30% +$1.99M 0.03% 601
2024
Q3 		$6.6M Buy
366,200
+223,300
+156% +$3.91M 0.01% 971
2024
Q2 		$2.32M Buy
142,900
+73,000
+104% +$1.12M ﹤0.01% 1965
2024
Q1 		$986K Buy
69,900
+45,500
+186% +$574K ﹤0.01% 2607
2023
Q4 		$255K Buy
24,400
+13,900
+132% +$130K ﹤0.01% 3500
2023
Q3 		$107K Buy
10,500
+4,400
+72% +$41K ﹤0.01% 3912
2023
Q2 		$45.9K Buy
+6,100
New +$49.5K ﹤0.01% 3658
2022
Q4 		– Sell
-43,800
Closed -$353K – 3632
2022
Q3 		$353K Buy
+43,800
New +$387K 0.01% 1704
2020
Q1 		– Sell
-219,800
Closed -$2.15M – 1637
2019
Q4 		$2.15M Sell
219,800
-173,600
-44% -$1.55M 0.14% 179
2019
Q3 		$2.71M Buy
393,400
+353,200
+879% +$2.71M 0.16% 149
2019
Q2 		$371K Sell
40,200
-23,300
-37% -$281K 0.04% 639
2019
Q1 		$996K Buy
+63,500
New +$1.12M 0.16% 165

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Walleye Capital's TEVA Position: Q2 2026 in Review

Walleye Capital sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 2,309 shares — an estimated $76.9K sold.

Walleye Capital first reported a position in TEVA in Q1 2019 and held it in 13 quarters. The position peaked at $22.2M in Q4 2024. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Walleye Capital reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 2,309 Teva Pharmaceuticals shares in Q2 2026, an estimated $76.9K.
  • Walleye Capital first reported a position in Teva Pharmaceuticals in Q1 2019 and held it in 13 quarters.
  • Walleye Capital's Teva Pharmaceuticals position peaked at $22.2M in Q4 2024.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.